MTOR and glioblastoma: Venkatesh et al. [28] has also demonstrated that treatment with the PI3K inhibitor LY294002 and mTOR inhibitor everolimus decreased phosphocholine levels associated with decreased in choline kinase activity in glioblastoma cell lines.